Çѱ¹°£´ãÃé¿Ü°úÇÐȸ 16th Single Topic Symposium (STS 2022) : 2022-09-16±³À°ÀÏÀÚ : 2022-09-16
±³À°Àå¼Ò : °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
16th Single Topic Symposium (STS 2022)ÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
´ã´çÀÚ : À̺¸¹Ì
¿¬¶ôó : 02-2051-8299
À̸ÞÀÏ :
khbps@khbp.or.kr ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 99¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
°æ»óºÏµµ±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 100,000¿ø
ºñ°í [Æò»ýȸ¿ø,Á¤È¸¿ø]»çÀüµî·Ï 50,000¿ø/ÀϹݵî·Ï 70,000¿ø [Àü°øÀÇ,°£È£»ç,±ºÀÇ°ü] »çÀüµî·Ï 30,000¿ø/ÀϹݵî·Ï 50,000¿ø [ºñȸ¿ø] »çÀüµî·Ï 70,000¿ø/ÀϹݵî·Ï 100,000¿ø [±¹³»°ÅÁÖ ¿Ü±¹ÀÎ] »çÀüµî·Ï 30,000¿ø/ÀϹݵî·Ï 50,000¿ø [ÀÇ°ú´ëÇÐ Çлý] ¹«·á
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 08:50~09:00 °³È¸½Ä ()
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 09:00~09:20 HCC development in virally suppressed or HBsAg seroconverted CHB patients ÃÖÁ¾±â(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 09:20~09:40 Precision liver resection toward better outcomes ±èºÀ¿Ï(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 09:40~10:00 Liver transplantation: recent achievements and future direction À̱¤¿õ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 10:00~10:20 Update of systemic therapy for HCC ÀÌÇö¿õ(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 10:20~10:40 Break ()
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 10:40~11:00 (A) Optimal indication and timing of conversion surgery after neoadjuvant treatment (NAT) - Gastroenterologist's view ±èµ¿¿í(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 11:00~11:20 (A) Optimal indication and timing of conversion surgery after neoadjuvant treatment (NAT) - Surgeon's view ÀåÁø¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 11:20~11:40 (B) Burdens and practical agony of physician and surgeon during treatment - Gastroenterologist's view: Complication, changing regimen À±½Â¹è(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 11:40~12:00 (B) Burdens and practical agony of physician and surgeon during treatment - Surgeon's view: Decision during operation (Resection vs Dissection of vessel) Ȳ´ë¿í(¿ï»êÀÇ´ë)
½Ä»ç 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 12:00~13:00 Á¡½É½Ã°£ ()
±âŸ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 13:00~13:50 Ư° (¸ÞŸ¹ö½º ´ëÇ×ÇØ ½Ã´ëÀÇ Àηù) ±è´ë½Ä(Ä«À̽ºÆ®)
ÈÞ½Ä 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 13:50~14:10 Break ()
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 14:10~14:30 Diagnostic role of endoscopic retrograde cholangiopancreatography and spyglass ±ÇâÀÏ(Â÷ÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 14:30~14:50 Palliative endoscopic treatment: Photodynamic therapy, radiofrequency ablation with biliary stent Á¶ÀçÈñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 14:50~15:10 Aggressive surgical approaches for advanced bile duct cancer Ȳ½Å(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 15:10~15:30 Conversion surgery after neoadjuvant chemotherapy for advanced bile duct cancer ¹ÚÁؼº(¿¬¼¼ÀÇ´ë)
ÈÞ½Ä 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 15:30~15:50 Break ()
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 15:50~16:00 (A) The resectability of HCC based on the tumor size, number and vascular invasion - Surgeon's view ÀÌÇØ¿ø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 16:00~16:10 (A) The resectability of HCC based on the tumor size, number and vascular invasion - Hepatologist view ¹ÚÁØ¿ë(¿¬¼¼ÀÇ´ë)
Åä·Ð 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 16:10~16:40 Panel discussion ¹ÚÁ¤ÀÍ(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 16:40~16:50 (B) The definition of down staging for liver transplantation: From ideals to clinical practice - Surgeon's view ±èµ¿½Ä(°í·ÁÀÇ´ë)
±³À°½Ã°£ 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 16:50~17:00 (B) The definition of down staging for liver transplantation: From ideals to clinical practice - Hepatologist view ÀåÁ¤¿ø(°¡Å縯ÀÇ´ë)
Åä·Ð 09-16 °æÁÖ ¶óÇѼ¿·ºÆ® ÄÁº¥¼ÇȦ 17:00~17:30 Panel discussion ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
±âŸ 09-16 17:30~17:40 Æóȸ½Ä ()